| Name | Title | Contact Details |
|---|
Ovid Therapeutics is a biopharmaceutical company focused exclusively on developing impactful medicines for patients and families living with rare neurological disorders. Ovid`s drug candidate, OV101, is currently in development for the treatment of symptoms of Angelman syndrome and Fragile X syndrome. Ovid is also developing OV935 in collaboration with Takeda Pharmaceutical Company Limited for the treatment of rare epileptic encephalopathies. Ovid has initiated the Phase 2 STARS trial of OV101 in adults with Angelman syndrome and a Phase 1 trial in adolescents with Angelman and Fragile X syndrome to identify doses suitable for younger patients.
Weiler Engineering is a Arlington Heights, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Philcare Home Inc is a Warminster, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Publ Hlth Res Inst is a Newark, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
New England Institutional Review Board NEIRB is a Newton, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.